Table 3.

Univariate factors associated with pre–CAR-T QOL

Variable	β (95% CI)	Standard error	P value
Age (y)	0.54 (0.26-0.82)	0.14	< .001
Female sex	−1.48 (−8.61 to 5.65)	3.59	.682
Married/with a partner	6.51(–1.80 to 14.8)	4.18	.123
College educated	7.91 (1.06-14.7)	3.45	.024
Income ≥ $100 000	7.94 (0.88-15.0)	3.55	.028
White race	6.96 (−3.44 to 17.4)	5.24	.187
Bridging therapy use	−8.99 (–16.2 to –1.82)	3.61	.015
ECOG performance status	−9.91 (–15.4 to –4.46)	2.74	< .001
Diagnosis of lymphoma/leukemia	3.80 (−3.78 to 11.4)	3.82	.322
Months since diagnosis	−0.04 (−0.11 to 0.03)	0.03	.236
CAR-T product
B-cell maturation antigen CAR-T (ref)	Ref	Ref	Ref
Tisa-cel	0.06 (−8.72 to 8.83)	4.42	.990
Axi-cel or Brexu-cel	8.37 (−1.71 to 18.4)	5.07	.102
Liso-cel	6.21 (−4.42 to 16.8)	5.35	.249

Ref., reference.

β-weights indicate differences in FACT-G QOL score based on each univariate predictor. Bolded values are for those with a P value < 0.05.